Eugia Pharma Specialities Profile
Key Indicators
- Authorised Capital ₹ 800.00 Cr
- Paid Up Capital ₹ 621.01 Cr
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 724.00 Cr
- Revenue Growth 16.26%
- Profit Growth -27.05%
- Ebitda 14.54%
- Net Worth 29.60%
- Total Assets 26.70%
About Eugia Pharma Specialities
Eugia Pharma Specialities Limited (EPSL) is a leading Public Limited Indian Non-Government Company incorporated in India on 17 April 2013 and has a history of 11 years and nine months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 800.00 Cr and a paid-up capital of Rs 621.01 Cr.
The company has closed loans amounting to ₹724.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Eugia Pharma Specialities Limited India are Yugandhar Puvvala as Ceo, Vallamkondu Kumar as Cfo, and Venkat Kupireddy as Company Secretary. Ragunathan Kannan, Santhanam Subramanian, Veerayya Kosaraju, and Three other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24297TG2013PLC087048
- Company No.
087048
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2013
- Date of AGM
22 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Eugia Pharma Specialities?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yugandhar Puvvala  | CEO | 01-Oct-2021 | Current |
| Vallamkondu Kumar | CFO | 21-Feb-2024 | Current |
| Venkat Kupireddy | Company Secretary | 10-Jun-2019 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sundari Pisupati | Director | 01-Dec-2021 | Current |
| Ragunathan Kannan | Director | 01-Dec-2021 | Current |
| Santhanam Subramanian | Director | 01-Oct-2021 | Current |
| Veerayya Kosaraju | Director | 01-Dec-2021 | Current |
| Yugandhar Puvvala | Director and Ceo | 01-Dec-2021 | Current |
| Madan Mettu | Director | 17-Apr-2013 | Current |
Financial Performance of Eugia Pharma Specialities.
Eugia Pharma Specialities Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.26% increase. The company also saw a substantial fall in profitability, with a 27.05% decrease in profit. The company's net worth Soared by an impressive increase of 29.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eugia Pharma Specialities?
In 2023, Eugia Pharma Specialities had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pravesha Industries Private LimitedMadan Mettu is a mutual person
My Home Industries Private LimitedVeerayya Kosaraju is a mutual person
Genome FoundationVeerayya Kosaraju is a mutual person
Sathguru Management Consultants Pvt LtdRagunathan Kannan is a mutual person
Divi's Laboratories LimitedVeerayya Kosaraju is a mutual person
Fernandez FoundationRagunathan Kannan is a mutual person
Charges (Loans)
₹0
₹724.00 Cr
Charges Breakdown by Lending Institutions
- Others : 605.00 Cr
- Export Import Bank Of India : 119.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2019 | Others | ₹105.00 Cr | Satisfied |
| 06 Jul 2017 | Others | ₹500.00 Cr | Satisfied |
| 24 Feb 2014 | Export Import Bank Of India | ₹119.00 Cr | Satisfied |
How Many Employees Work at Eugia Pharma Specialities?
Eugia Pharma Specialities has a workforce of 2490 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eugia Pharma Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eugia Pharma Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
